Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review

S Łukasiewicz, M Czeczelewski, A Forma, J Baj… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

Regulation of ZMYND8 to treat cancer

Y Chen, YH Tsai, SH Tseng - Molecules, 2021 - mdpi.com
Zinc finger myeloid, nervy, and deformed epidermal autoregulatory factor 1-type containing
8 (Zinc finger MYND-type containing 8, ZMYND8) is a transcription factor, a histone H3 …

ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells

M Luo, L Bao, Y Chen, Y Xue, Y Wang, B Zhang… - Science …, 2022 - science.org
27-Hydroxycholesterol (27-HC) is the most abundant oxysterol that increases the risk of
breast cancer progression. However, little is known about epigenetic regulation of 27-HC …

The dual function of KDM5C in both gene transcriptional activation and repression promotes breast cancer cell growth and tumorigenesis

H Shen, W Zhang, Y Huang, Y He, G Hu… - Advanced …, 2021 - Wiley Online Library
Emerging evidence suggested that epigenetic regulators can exhibit both activator and
repressor activities in gene transcriptional regulation and disease development, such as …

Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity

H Wang, Y Fan, W Chen, Z Lv, S Wu, Y Xuan… - …, 2022 - Taylor & Francis
Recent studies have revealed that chemokine-like factor-like MARVEL transmembrane
domain-containing family member 6 (CMTM6) promotes tumor progression and modulates …

VHL suppresses UBE3B-mediated breast tumor growth and metastasis

S Wang, H Li, X Liu, T Yin, T Li, M Zheng, M Liu… - Cell Death & …, 2024 - nature.com
Protein homeostasis is predominantly governed through post-translational modification
(PTM). UBE3B, identified as an oncoprotein, exhibits elevated protein levels in breast …

ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2

M Luo, L Bao, Y Xue, M Zhu, A Kumar… - The Journal of …, 2024 - Am Soc Clin Investig
Breast cancer stem cells (BCSCs) mitigate oxidative stress to maintain their viability and
plasticity. However, the regulatory mechanism of oxidative stress in BCSCs remains unclear …

Zinc finger MYND-type containing 8 (ZMYND8) is epigenetically regulated in mutant isocitrate dehydrogenase 1 (IDH1) glioma to promote radioresistance

SV Carney, K Banerjee, A Mujeeb, B Zhu, S Haase… - Clinical Cancer …, 2023 - AACR
Purpose: Mutant isocitrate dehydrogenase 1 (mIDH1) alters the epigenetic regulation of
chromatin, leading to a hypermethylation phenotype in adult glioma. This work focuses on …

[HTML][HTML] Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer

F Qiu, Y Jin, J Pu, Y Huang, J Hou, X Zhao… - Experimental Cell …, 2021 - Elsevier
ZMYND8, an epigenetic regulator, was identified as a common oncogene across various
tumors. However, little was reported about the association between ZMYND8 and bladder …

PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer

S Gao, W Zhang, J Ma, X Ni - Journal of Translational Medicine, 2023 - Springer
Background Aberrant epigenetic remodeling events contribute to progression and
metastasis of breast cancer (Bca). The specific mechanims that epigenetic factors rely on to …